Evidence map›Paper›PMID 40452843›Full record

ArticleFrontiers in oncology2025

Metastasis of prostate cancer to breast: a case report.

Sirui Zhang, Wenting Peng, Lin Cheng, Bei Pei, Xiaoli Zhou, Mengjie Wang, Ling Jiang, Chao Lu, Lingyun Xu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Molecular imaging and radionuclide therapy · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sirui ZhangDepartment of Breast Surgery, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Second People's Hospital, Changzhou, Jiangsu, China.
Wenting PengDepartment of Breast Surgery, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Second People's Hospital, Changzhou, Jiangsu, China.
Lin ChengDepartment of Breast Surgery, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Second People's Hospital, Changzhou, Jiangsu, China.
Bei PeiDepartment of Breast Surgery, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Second People's Hospital, Changzhou, Jiangsu, China.
Xiaoli ZhouDepartment of Pathology, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Second People's Hospital, Changzhou, Jiangsu, China.
Mengjie WangDepartment of Oncology, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Second People's Hospital, Changzhou, Jiangsu, China.
Ling JiangDepartment of Breast Surgery, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Second People's Hospital, Changzhou, Jiangsu, China.
Chao Lu *Department of Urology Surgery, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Second People's Hospital, Changzhou, Jiangsu, China.
Lingyun Xu *Department of Breast Surgery, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Second People's Hospital, Changzhou, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe a 68-year-old man who had prostate cancer (PCa) diagnosed with breast metastasis, presenting as a breast mass. Seven years ago, the patient had PCa with bone metastasis and had been systematically receiving endocrine therapy for prostate cancer and osteoprotective treatment since the diagnosis. In October 2023, the patient visited our hospital due to bilateral breast masses for four days. Enlarged supraclavicular lymph nodes were detected, while multiple solid space-occupying lesions were observed in bilateral mammary tissues, classified as Breast imaging reporting and data system (BI-RADS) 4C. Subsequently, he underwent lumpectomy and was diagnosed with metastatic prostatic acinar adenocarcinoma.

Indexed as

androgen receptorBRCA mutationsbreast metastasisdifferential diagnosismale breast cancerprostate cancer

Identifiers

PMID40452843
PMCPMC12122736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.